Clotted blood samples in the neonatal intensive care unit: A retrospective, observational study to evaluate interventions to reduce blood sample clotting
Nursing in Critical Care · 2024
DOI: 10.1111/nicc.12941 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nursing in Critical Care, 2024. Verfasst von Matheus F P T van Rens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Intensive Care Units, Neonatal, Blood Specimen Collection, Quality Improvement. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Center (MRC), Hamad Medical Corporation (HMC).
Themen: Neonatologie, Intensivpflege
Abstract (Originalsprache)
Background
Blood draws for laboratory investigations are essential for patient management in neonatal intensive care units (NICU). When blood samples clot before analysis, they are rejected, which delays treatment decisions and necessitates repeated sampling.
Aim
To decrease the incidence of rejected blood samples taken for laboratory investigation as a result of clotted sample. Study Design This retrospective observational study used routine data on blood draws from preterm infants collected between January 2017 and June 2019 in a 112‐cot NICU in Qatar. Quality improvement interventions to reduce the rate of clotted blood samples included: awareness raising and safe sampling workshops with NICU staff, involvement of the neonatal vascular access team, development of a complete blood count (CBC) sample collection pathway, review of sample collection equipment, introducing the Tenderfoot® heel lance, establishment of benchmarks and provision of dedicated blood extraction equipment.
Results
First attempt blood draw occurred in 10 706 cases, representing a 96.2% success rate. In 427 (3.8%) cases, the samples were clotted requiring repeat collection. The overall rate of clotted specimens decreased from 4.8% in 2017 and 2018 to 2.4% in 2019, with odds ratios of 1.42 (95% confidence interval [CI] 1.13–1.78, p = .002), 1.46 (95% CI 1.17–1.81, p < .001) and 0.49 (95% CI 0.39–0.63, p < .001), respectively. The majority (87%–95%) of blood samples were by venepuncture using an intravenous (IV) catheter or the NeoSafe™ blood sampling device. Heel prick sampling was the second (2%–9%) most common method. Clotted samples were most frequently associated with needle use, 228 of 427 (53%), and IV cannula, 162 of 427 (38%), with odds ratios of 4.14 (95% CI 3.34–5.13, p < .001) and 3.11 (95% CI 2.51–3.86, p < .001), respectively.
Conclusions
Our interventions over 3 years were associated with reduced rates of sample rejection due to clotting, and this led to improved patient experience through fewer repeated samplings. Relevance to Clinical Practice The insights gained from this project can help to improve patient care. Interventions that reduce the rate of blood sample rejection by clinical laboratories can lead to economic savings, timelier diagnostic and treatment decisions, and contribute to an improved quality care experience for all critical care patients, irrespective of age, by reducing the need for repeated phlebotomy and the risk of related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neonatal Intensive Care Unit, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
- Department of Nursing and Midwifery Education, Hamad Medical Corporation, Doha, Qatar.
- Department of Quality Improvement, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.
- Anaesthesiology, Intensive Care and Pain Medicine, Catharina Hospital, Eindhoven, the Netherlands.
- PeriOperative Care & Technology, Fontys University of Applied Sciences, Eindhoven, the Netherlands.
- Global Vascular Access LLC, Scottsdale, Arizona, USA.
ORCID-Profile: Matheus F P T van Rens, Kevin Hugill, Airene L V Francia, Fredericus H J van Loon, Timothy R Spencer, Mohammad A A Bayoumi
Förderung
- Medical Research Center (MRC)
- Hamad Medical Corporation (HMC)
Zitieren
APA
van Rens, M. F. P. T., Hugill, K., Francia, A. L. V., Macaraig, A. V., van Loon, F. H. J., Spencer, T. R., & Bayoumi, M. A. A. (2024). Clotted blood samples in the neonatal intensive care unit: A retrospective, observational study to evaluate interventions to reduce blood sample clotting. Nursing in Critical Care. https://doi.org/10.1111/nicc.12941
Vancouver
van Rens MFPT, Hugill K, Francia ALV, Macaraig AV, van Loon FHJ, Spencer TR, et al. Clotted blood samples in the neonatal intensive care unit: A retrospective, observational study to evaluate interventions to reduce blood sample clotting. Nursing in Critical Care. 2024. doi:10.1111/nicc.12941
BibTeX
@article{vanRens2024,
author = {van Rens, Matheus F P T and Hugill, Kevin and Francia, Airene L V and Macaraig, Abraham Victor and van Loon, Fredericus H J and Spencer, Timothy R and Bayoumi, Mohammad A A},
title = {Clotted blood samples in the neonatal intensive care unit: A retrospective, observational study to evaluate interventions to reduce blood sample clotting},
journal = {Nursing in Critical Care},
year = {2024},
doi = {10.1111/nicc.12941}
}
EUVIMED